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INTRODUCTION
Hidradenoma papilliferum (HP) is a benign neoplasm in-
volving anogenital mammary-like glands (MLG) and occurs 
most commonly in the vulva or perianal region of adult white 
women [1,2]. It is histopathologically similar to intraductal pap-
illoma of the breast. The lesions are usually solitary, well-de-
marcated papules or nodules covered with normal skin, and 
are generally less than 10 mm in diameter [3]. When these tu-
mors are not located in the anogenital area, they are termed 
ectopic HP [4]. 
MLG have been documented in ectopic areas of the skin such 
as the ear, face, chest, and scalp. Ectopic HP can arise from any-
where which MLG are located. Most of all are excised without 
suspicious. As a result, its imaging findings are not well known. 
Then, the purpose of our report was to provide imaging find-
ings of ectopic HP in axillary tail of the breast as rare location.
CASE REPORT
A 46-year-old woman presented with a 5-year history of a 
slowly growing, palpable mass on the left breast. Physical ex-
amination revealed a 4 cm, soft and movable, brown colored 
mass at the 2 o’clock location in the axillary tail region of the 
left breast. She had no remarkable medical or family history. 
An ultrasound (iU22 unit; Philips Medical Systems, Bothell, 
USA) of the left breast revealed grouped, 1-2 cm, well-circum-
scribed, round solid masses with internal cystic components 
in the dermis that abutted the subcutaneous layer of the left 
breast (Figure 1) and were located in the axillary tail. Radiologi-
cally, these lesions were considered to be Breast Imaging Re-
porting and Data System (BI-RADS) Category 3 [5]. Provi-
sional diagnosis of atypical dermoid cysts had been postulat-
ed. She underwent surgical excision. 
Grossly, Part of the nodules was well encapsulated, lobular 
masses with purple-brown cut surface that abutted but didn’t 
penetrate the skin (Figure 2). Hematoxylin and eosin (H&E) 
sections, ×1 (Figure 3A) and ×200 (Figure 3B) revealed der-
mally based nodules with complex architecture and uninvolved 
epidermis. The nodules consisted of a cyst with large arboriz-
ing papillae which had fibrovascular core. The non-neoplastic 
breast tissue underneath the tumor showed focal apocrine meta-
plasia. Microscopically, the lesions are cystic papillary tumors 
and are composed of proliferation of papillary fronds made of 
loose fibrous connective tissue lined by pseudostratified bland-
looking epithelial cells. Histologic examination of the lesion 
revealed findings consistent with HP. The immunohistochem-
ical staining for estrogen receptor (ER) or progesterone recep-
tor (PR) were all positive and HER2 protein was negative.
DISCUSSION
HP is a skin appendage tumor that is most commonly re-
ported on the anogenital region of women, particularly the 
vulva. HP has been considered to be derived from apocrine 
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glands. However, the observed similarities of HP with intra-
ductal papillomas of the breast indicate that MLG is the true 
origin of HP. HP primarily affects Caucasian females, typically 
during the third to fifth decades of life. Ectopic HPs occur on 
non-anogenital sites in older patients, with an equal incidence 
in males and females [4]. 
MLG are normal finding in the anogenital region of males 
and especially females. MLG are located in the subepidermal 
stroma, larger than apocrine or eccrine glands, frequently 
branched and sometimes truly lobulated, lined by basophilic 
rather than eosinophilic cells and are ER or PR positive. MLG 
have been documented in ectopic areas of the skin such as the 
ear, face, chest, and scalp [4]. Therefore, the ectopic HP could 
occur in these regions and 19 cases of ectopic HPs have been 
reported in the English language literature (Table 1). Most com-
mon site of ectopic HPs was on head and neck. 
The classification of cutaneous sweat gland lesions is very 
complex, as these lesions have a wide histological spectrum, 
and the pathogenesis and exact origin of many of these lesions 
is still under investigation and is unclear. Many different terms 
are often used to describe the same tumor. Eccrine sweat glands 
are widely distributed almost everywhere in the skin, but apo-
crine lesions of the skin are rare and are found mainly in body 
folds including the axillary, groin, and anogenital regions. 
HP is usually solitary, small, and asymptomatic. Occasion-
ally, the tumors can be large and elevated, forming a reddish-
brown mass with an ulcerated and bleeding surface. The inci-
dence of multiple lesions is reported as 5% and all multiple le-
sions have been described as unilateral [6]. Histologically, it is 
a well-circumscribed, solid or cystic, dermal nodular lesion, 
not connected to the epidermis. The prognosis for both ano-
genital and ectopic HP is good. Regardless of the site, the treat-
ment of choice is local excision. Recurrence of anogenital and 
ectopic HP is unusual and is typically attributed to incomplete 
Figure 1. Ultrasound shows three, round complex masses in the der-
mis which abutted the subcutaneous fat layer of the left breast.
Figure 2. Excisied specimen shows two well circumscribed solid and 
partly cystic masses. 
A B
Figure 3. Microscopic findings of the lesions (A, H&E stain, ×1; B, H&E stain, ×200). The lesions are composed of proliferation of papillary fronds made 
of loose fibrous connective tissue lined by pseudostratified bland-looking epithelial cells. These findings are consistent with the cystic papillary tumors.HidradenomaPapilliferum 155
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excision of the primary tumor. Malignant transformation is rare. 
In women, anogenital and ectopic HP tumors have only been 
reported after the onset of puberty. Hence it is possible that es-
trogen stimulation may play a role in the pathogenesis of HP 
in women. Whether estrogens are involved in ectopic HP in 
men remains to be evaluated. Typical eccrine and apocrine 
sweat glands were devoid of both ER and PR. Thus, ER and 
PR seem to be reliable markers for distinguishing female ano-
genital glands from conventional sweat glands [7]. Our case 
was also positive for ER and PR on immunohistochemical stain-
ing. However, our case arose from the breast dermis. It is im-
portant to remember that ER and PR positivity has been de-
scribed in a subset of breast cancers, including papillary neo-
plasms. Accordingly, ER and PR immunohistochemical stain-
ing should not be used to distinguish breast tumors from HP. 
HER2 protein is also useful immunostain to distinguish breast 
adenocarcinoma from skin adnexal tumors. Less than 0.5% of 
cutaneous eccrine and apocrine neoplasms are associated with 
positive HER2 immunohistochemical staining [8], whereas 
20% of invasive breast adenocarcinomas are HER2 positive. 
Ultrasound is used to identify and characterize such masses. 
Complex cystic breast masses demonstrate both anechoic (cyst- 
ic) and echogenic (solid) components on ultrasound. Common 
benign findings include fibrocystic changes and intraductal or 
intracystic papillomas. Moreover, HP has features analogous to 
an intraductal papilloma of the breast which can lead to mis-
diagnosis. But, most papillomas are located in breast parenchy-
ma and are related to ducts, although some peripheral type of 
papilloma looks like only solid mass. 
Adnexal tumor appears as a fairly well-demarcated cystic-sol-
id mass in the dermis and HPs have similar findings. Due to 
the rarity of this tumor, and its common removal without im-
aging studies because of small size, typical radiological find-
ings have not yet been well established.
In conclusion, skin adnexal tumors, specifically HP, should 
be kept in the differential diagnosis when evaluating a subcuta-
neous breast tumor. To our knowledge, this is the first case re-
port of HP developed in the breast skin of middle-aged woman.
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Table 1. Nineteen cases of ectopic hidradenoma papilliferum in the English language literature
Case no. Sex/Age Location Size (mm) Author (published year)
  1 M/8 Thigh (2 at the same site)   5 Schewach-Millet et al. (1984)
  2 F/32 External auditory canal 10 Nissim et al. (1981) 
  3 M/37 Nose 30 Smith et al. (2003)
  4 F/45 Eyelid ? Santa Cruz et al. (1981)
  5 F/46 Nose 10 Lee et al. (2010)
  6 F/48 Back 20 Fernández-Aceñero et al. (2003)
  7 F/55 Cheek 12 Ioannides (1966)
  8 M/55 Postauricular   5 Binns (1974)
  9 F/56 Forhead 11 Ioannides (1966)
10 M/56 Eyebrow 16 Minami et al. (2006)
11 F/60 Eyelid   6 Ioannides (1966)
12 F/61 Forhead   6 Ioannides (1966)
13 M/61 Axilla 15 Ioannides (1966)
14 M/62 Chest   8 Tanaka et al. (2003)
15 F/63 Back 40 Ioannides (1966)
16 F/66 Nose   7 Lee et al. ( 2010)
17 M/72 Proximal arm   6 Vang et al. (1999)
18 F/75 Scalp 60 Goette (1988)
19 M/78 Eyelid   6 Netland et al. (1990)